Literature DB >> 28518152

STAT5 alters the state of transcriptional networks, driving aggressive leukemia.

Sinisa Dovat1, Kimberly J Payne2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28518152     DOI: 10.1038/ni.3747

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  12 in total

1.  IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL.

Authors:  R P Kuiper; E Waanders; V H J van der Velden; S V van Reijmersdal; R Venkatachalam; B Scheijen; E Sonneveld; J J M van Dongen; A J P Veerman; F N van Leeuwen; A Geurts van Kessel; P M Hoogerbrugge
Journal:  Leukemia       Date:  2010-05-06       Impact factor: 11.528

2.  Deaths: final data for 2010.

Authors:  Sherry L Murphy; Jiaquan Xu; Kenneth D Kochanek
Journal:  Natl Vital Stat Rep       Date:  2013-05-08

Review 3.  The role of STAT5 in lymphocyte development and transformation.

Authors:  Lynn M Heltemes-Harris; Michael A Farrar
Journal:  Curr Opin Immunol       Date:  2012-02-16       Impact factor: 7.486

Review 4.  STAT5 in B cell development and leukemia.

Authors:  Stephen Malin; Shane McManus; Meinrad Busslinger
Journal:  Curr Opin Immunol       Date:  2010-03-11       Impact factor: 7.486

5.  Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2.

Authors:  J Schwaller; E Parganas; D Wang; D Cain; J C Aster; I R Williams; C K Lee; R Gerthner; T Kitamura; J Frantsve; E Anastasiadou; M L Loh; D E Levy; J N Ihle; D G Gilliland
Journal:  Mol Cell       Date:  2000-09       Impact factor: 17.970

6.  Master transcription factors and mediator establish super-enhancers at key cell identity genes.

Authors:  Warren A Whyte; David A Orlando; Denes Hnisz; Brian J Abraham; Charles Y Lin; Michael H Kagey; Peter B Rahl; Tong Ihn Lee; Richard A Young
Journal:  Cell       Date:  2013-04-11       Impact factor: 41.582

Review 7.  Acute lymphoblastic leukaemia.

Authors:  Hiroto Inaba; Mel Greaves; Charles G Mullighan
Journal:  Lancet       Date:  2013-03-22       Impact factor: 79.321

8.  Stat5 is indispensable for the maintenance of bcr/abl-positive leukaemia.

Authors:  Andrea Hoelbl; Christian Schuster; Boris Kovacic; Bingmei Zhu; Mark Wickre; Maria A Hoelzl; Sabine Fajmann; Florian Grebien; Wolfgang Warsch; Gabriele Stengl; Lothar Hennighausen; Valeria Poli; Hartmut Beug; Richard Moriggl; Veronika Sexl
Journal:  EMBO Mol Med       Date:  2010-03       Impact factor: 12.137

9.  Role of STAT5 in controlling cell survival and immunoglobulin gene recombination during pro-B cell development.

Authors:  Stephen Malin; Shane McManus; César Cobaleda; Maria Novatchkova; Alessio Delogu; Philippe Bouillet; Andreas Strasser; Meinrad Busslinger
Journal:  Nat Immunol       Date:  2009-11-29       Impact factor: 25.606

10.  Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia.

Authors:  Charles G Mullighan; Xiaoping Su; Jinghui Zhang; Ina Radtke; Letha A A Phillips; Christopher B Miller; Jing Ma; Wei Liu; Cheng Cheng; Brenda A Schulman; Richard C Harvey; I-Ming Chen; Robert J Clifford; William L Carroll; Gregory Reaman; W Paul Bowman; Meenakshi Devidas; Daniela S Gerhard; Wenjian Yang; Mary V Relling; Sheila A Shurtleff; Dario Campana; Michael J Borowitz; Ching-Hon Pui; Malcolm Smith; Stephen P Hunger; Cheryl L Willman; James R Downing
Journal:  N Engl J Med       Date:  2009-01-07       Impact factor: 91.245

View more
  2 in total

1.  Attenuated IL-2R signaling in CD4 memory T cells of T1D subjects is intrinsic and dependent on activation state.

Authors:  Katharine Schwedhelm; Jerill Thorpe; Sara A Murray; Marc Gavin; Cate Speake; Carla Greenbaum; Karen Cerosaletti; Jane Buckner; S Alice Long
Journal:  Clin Immunol       Date:  2017-06-20       Impact factor: 3.969

2.  Ikaros antagonizes DNA binding by STAT5 in pre-B cells.

Authors:  Beate Heizmann; Stéphanie Le Gras; Célestine Simand; Patricia Marchal; Susan Chan; Philippe Kastner
Journal:  PLoS One       Date:  2020-11-12       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.